Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-08

Clinical Trial Update: Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating toripalimab in combination with etoposide and platinum chemotherapy as first-line treatment for genitourinary small cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Toripalimab, First-line Treatment | Phase 2 | Status: UNKNOWN